Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Pulmonary Hypertension

Free Subscription 23.03.2026 2 Adv Ther 1 Animal Model Exp Med 1 Ann Am Thorac Soc 1 Arthritis Rheumatol 2 AsiaIntervention 1 Biochem Biophys Res Commun 1 Biomed Res Int 1 Cells 1 Circ Heart Fail 1 Diagnostics (Basel) 1 ERJ Open Res 1 Eur J Intern Med 1 Eur J Pharmacol 1 Eur Radiol Exp 1 Eur Respir J 1 Heart Lung 1 Hypertension 1 Int J Cardiol 2 Int J Mol Sci 1 Intern Emerg Med 1 J Am Heart Assoc 1 J Am Soc Echocardiogr 1 J Cardiothorac Vasc Anesth 1 J Ethnopharmacol 2 J Heart Lung Transplant 1 J Intensive Care Med 1 J Med Econ 1 J Med Genet 1 JAMA Ophthalmol 1 Mol Cell Endocrinol 1 Nat Commun 1 Neonatology 1 Orphanet J Rare Dis 1 Pediatrics 1 Ren Fail 1 Respir Med 1 Respir Med Res 1 Rheumatology (Oxford) 1 Ter Arkh

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Adv Ther

1. LAROY V, Roberts E, Mayeux J, Patzlaff N, et al
   Advances in and Clinical Experience with Subcutaneous Infusion Pump Therapy for Pulmonary Arterial Hypertension.
   Adv Ther. 2026;43:919-934.
   PubMed         Abstract available
   
   
2. LACHANT D, Raina A, Krishnan M, Sood N, et al
   Efficacy and Safety of Oral Treprostinil in Patients with Pulmonary Arterial Hypertension on Background Monotherapy or Dual Therapy.
   Adv Ther. 2026;43:1308-1326.
   PubMed         Abstract available
   
   

   
   Animal Model Exp Med

3. ZHU YJ, Zhou LC, Zhang XX, Ren XY, et al
   Animal models of chronic thromboembolic pulmonary hypertension.
   Animal Model Exp Med. 2026 Mar 16. doi: 10.1002/ame2.70167.
   PubMed         Abstract available
   
   

   
   Ann Am Thorac Soc

4. GILLMEYER KR, Rinne ST, Klings ES, Elwy AR, et al
   Provider networks for pulmonary hypertension in Massachusetts: implications for improving referrals to expert care.
   Ann Am Thorac Soc. 2026;23:369-378.
   PubMed         Abstract available
   
   

   
   Arthritis Rheumatol

5. KIM JS, Wallwork RS, Richardson CL, Woods A, et al
   Identification of Risk Factors for Incident Left Ventricular Systolic Dysfunction and Predictors of Cardiac Recovery in Patients With Systemic Sclerosis.
   Arthritis Rheumatol. 2026;78:713-723.
   PubMed         Abstract available
   
   

   
   AsiaIntervention

6. HART JP, Davies MG
   Flipping the focus - treating post-capillary pulmonary hypertension with pulmonary artery denervation.
   AsiaIntervention. 2026;12:14-16.
   PubMed        
   
   
7. JIANG X, Zhang H, Zhang J, Gu Y, et al
   Pulmonary artery denervation improves left ventricular diastolic function in patients with isolated post-capillary pulmonary hypertension secondary to heart failure with preserved ejection fraction: a safety and proof-of-principle cohort study.
   AsiaIntervention. 2026;12:41-49.
   PubMed         Abstract available
   
   

   
   Biochem Biophys Res Commun

8. HARA T, Adinata A, Suzuki Y, Asakura J, et al
   Application of murine hindlimb deep vein thrombosis model to assess temporal evolution and hemodynamic sequelae of pulmonary embolism.
   Biochem Biophys Res Commun. 2026;811:153558.
   PubMed         Abstract available
   
   

   
   Biomed Res Int

9. PANAHI M, Kalhor R, Mokhtarian MH, Tehrani FJ, et al
   Identification of Key Genes and Pathways Associated With Gender Differences in Pulmonary Arterial Hypertension Based on Bioinformatic Approaches.
   Biomed Res Int. 2026;2026:e9938078.
   PubMed         Abstract available
   
   

   
   Cells

10. RADA KM, Zuniga-Munoz AM, Alvarez-Alvarez YQ, Carbo R, et al
    The Role of the Apelin Receptor in the Pathophysiology of Pulmonary Arterial Hypertension.
    Cells. 2026;15:460.
    PubMed         Abstract available
    
    

    
    Circ Heart Fail

11. BELKIN MN, Fudim M, Baratto C, Grinstein J, et al
    Correction to: Standardization of Baseline and Provocative Invasive Hemodynamic Protocols for the Evaluation of Heart Failure and Pulmonary Hypertension: A Scientific Statement From the American Heart Association.
    Circ Heart Fail. 2026;19:e000090.
    PubMed        
    
    

    
    Diagnostics (Basel)

12. CHARISOPOULOU D, Koulaouzidis G, Kleitsioti P, Antoniou N, et al
    Stress Echocardiography in the Diagnosis and Evaluation of Pulmonary Hypertension: Practical Recommendations, Haemodynamic Phenotyping, and Application in Adults and Children.
    Diagnostics (Basel). 2026;16:792.
    PubMed         Abstract available
    
    

    
    ERJ Open Res

13. ARVANITAKI A, Diller GP, Lawrence A, Mukherjee B, et al
    Deep-learning networks accurately detect pulmonary hypertension in patients with idiopathic pulmonary fibrosis.
    ERJ Open Res. 2026;12:00672-2025.
    PubMed         Abstract available
    
    

    
    Eur J Intern Med

14. BIONDI F, Fiore VD, Pancani R, Carrozzi L, et al
    Exercise testing in chronic thromboembolic pulmonary hypertension and chronic thromboembolic pulmonary disease without pulmonary hypertension: a comprehensive systematic review and meta-analysis.
    Eur J Intern Med. 2026 Mar 13:106824. doi: 10.1016/j.ejim.2026.106824.
    PubMed         Abstract available
    
    

    
    Eur J Pharmacol

15. ZHANG Z, Ma X, Su C, Meng J, et al
    Perfluorocarbon ameliorates high-altitude pulmonary edema and blood-gas barrier dysfunction in a canine model and a lung-on-chip model by suppressing the HIF-1alpha/HO-1 pathway.
    Eur J Pharmacol. 2026;1019:178717.
    PubMed         Abstract available
    
    

    
    Eur Radiol Exp

16. VAINIO T, Makela T, Ruohola A, Arkko A, et al
    Deep learning-based identification of chronic pulmonary embolism on CTPA: a regional lung analysis using multiplanar MIP images.
    Eur Radiol Exp. 2026;10:32.
    PubMed         Abstract available
    
    

    
    Eur Respir J

17. POOR HD, Zhang J, Hannah-Clark S, Saini S, et al
    Sotatercept improves small airway disease and hyperinflation in patients with pulmonary hypertension.
    Eur Respir J. 2026 Mar 19:2502731. doi: 10.1183/13993003.02731-2025.
    PubMed        
    
    

    
    Heart Lung

18. VON VISGER TT, Chang YP
    Mindfulness meditation for pulmonary hypertension program development: Acceptability and feasibility of technology-assisted complementary health intervention for symptom self-management.
    Heart Lung. 2026;78:102759.
    PubMed         Abstract available
    
    

    
    Hypertension

19. MITRA A, Agarwal S, Chakraborty A, Zhong BL, et al
    Loss of ROR2 Tyrosine Kinase Receptor Is Associated With Endothelial Dysfunction in PAH via Inappropriate Integrin beta1 Activation.
    Hypertension. 2026;83:e25881.
    PubMed         Abstract available
    
    

    
    Int J Cardiol

20. CALLEGARI A, Malekzadeh-Milani S, Bonnet D
    Preoperative pulmonary hemodynamics and clinical decision making to determine operability and risk of long-term pulmonary hypertension in infants with open shunt under 1?year.
    Int J Cardiol. 2026 Mar 18:134437. doi: 10.1016/j.ijcard.2026.134437.
    PubMed         Abstract available
    
    

    
    Int J Mol Sci

21. LI X, Wang F, Liu N, Liu Y, et al
    Lactate Promotes Endothelial-Mesenchymal Transition via Mediating Twist1 Lactylation in Hypoxic Pulmonary Hypertension.
    Int J Mol Sci. 2026;27:2255.
    PubMed         Abstract available
    
    
22. OLDAKOWSKA AK, Kaminski KA, Ptaszynska K
    Iron Deficiency in Pulmonary Hypertension-Prevalence, Impact on Prognosis and Disease Burden in Pulmonary Arterial Hypertension and Pulmonary Hypertension Related to Hypoxia: A Review.
    Int J Mol Sci. 2026;27:2333.
    PubMed         Abstract available
    
    

    
    Intern Emerg Med

23. CATALANI F, Valeriani E, Ageno W, Campello E, et al
    Correction to: Anticoagulation in chronic thromboembolic pulmonary hypertension: an updated systematic review and meta-analysis.
    Intern Emerg Med. 2026 Mar 17. doi: 10.1007/s11739-026-04317.
    PubMed        
    
    

    
    J Am Heart Assoc

24. SATOH T, Sugimura K, Fukumoto Y, Abe K, et al
    Prognostic Impact of Elevated Pulmonary Vascular Resistance in Group 2 Pulmonary Hypertension: Insights From a Japanese Multicenter Registry.
    J Am Heart Assoc. 2026 Mar 20:e045155. doi: 10.1161/JAHA.125.045155.
    PubMed         Abstract available
    
    

    
    J Am Soc Echocardiogr

25. MARX J, Bikou O, Mazurek R, Sakata T, et al
    Optimal Method for Echocardiographic Right Ventricular Mass Estimation in Pulmonary Hypertension.
    J Am Soc Echocardiogr. 2026 Mar 17:S0894-7317(26)00128.
    PubMed        
    
    

    
    J Cardiothorac Vasc Anesth

26. LYHNE MD, Ellegaard MS, Korsholm KK, Hansen JV, et al
    Preoperative Right Ventricle-to-Pulmonary Artery Coupling Correlates With Intensive Care Length of Stay After Pulmonary Endarterectomy.
    J Cardiothorac Vasc Anesth. 2026;40:1171-1179.
    PubMed         Abstract available
    
    

    
    J Ethnopharmacol

27. WANG R, Wang Z, Weng Y, Zhang S, et al
    Insight of traditional Chinese medicine in treating pulmonary hypertension: Achievements from 2021 to 2025.
    J Ethnopharmacol. 2026;364:121545.
    PubMed         Abstract available
    
    

    
    J Heart Lung Transplant

28. HARBAUM L, Klose H, Lund J, Sinn M, et al
    Metabolomic signature of right ventricular-pulmonary arterial coupling differentiates hemodynamic response to imatinib therapy in pulmonary arterial hypertension.
    J Heart Lung Transplant. 2026;45:647-656.
    PubMed         Abstract available
    
    
29. ZARRABIAN B, Pennington KM, Cajigas HR, DuBrock HM, et al
    Comparative Outcomes of Bilateral Lung and Heart-Lung Transplantation in Primary Pulmonary Arterial Hypertension: A UNOS Database Study.
    J Heart Lung Transplant. 2025 Dec 16:S1053-2498(25)02419.
    PubMed         Abstract available
    
    

    
    J Intensive Care Med

30. DESCHAMPS J, Cornell E, Kumar N, Brusca S, et al
    Critical Care Management of the Patient with Pulmonary Hypertension.
    J Intensive Care Med. 2026 Mar 17:8850666261419481.
    PubMed         Abstract available
    
    

    
    J Med Econ

31. WATZKER A, Ferro C, Dieguez G, Girdish C, et al
    Loss of productivity among commercially insured patients with pulmonary arterial hypertension in the United States.
    J Med Econ. 2026;29:909-918.
    PubMed         Abstract available
    
    

    
    J Med Genet

32. WELCH CL, McEntagart M, Moledina S, Morgan C, et al
    Expanding the phenotypic spectrum of MECOM-associated syndrome: rare variants are associated with syndromic pulmonary arterial hypertension.
    J Med Genet. 2026;63:225-234.
    PubMed         Abstract available
    
    

    
    JAMA Ophthalmol

33. SINGH P, Kumar S, Tyagi R, Young BK, et al
    Deep Learning-Based Prediction of Cardiopulmonary Disease in Retinal Images of Premature Infants.
    JAMA Ophthalmol. 2026;144:230-237.
    PubMed         Abstract available
    
    

    
    Mol Cell Endocrinol

34. TASCA S, Turck P, Drosdowski D, Campos Carraro C, et al
    Comparative analysis of melatonin and sildenafil in a rat model of pulmonary arterial hypertension: Insights into oxidative stress, inflammation, and mitochondrial biogenesis.
    Mol Cell Endocrinol. 2026;616:112760.
    PubMed         Abstract available
    
    

    
    Nat Commun

35. YANAGISAWA H, Kuwahara K, Nakagawa Y, Moriuchi K, et al
    Endothelial C-type natriuretic peptide/guanylyl cyclase-B signaling prevents pulmonary arterial hypertension.
    Nat Commun. 2026;17:2331.
    PubMed         Abstract available
    
    

    
    Neonatology

36. MANI S, Berger SI
    Genetic Variants Associated with Persistent Pulmonary Hypertension of Newborn: A Systematic Review.
    Neonatology. 2026 Mar 13:1-22. doi: 10.1159/000550289.
    PubMed         Abstract available
    
    

    
    Orphanet J Rare Dis

37. JIN J, Su H, Wan Z, Zhao Y, et al
    Platelet gene signatures detecting pulmonary artery stenosis in patients with pulmonary hypertension.
    Orphanet J Rare Dis. 2026 Mar 13. doi: 10.1186/s13023-026-04307.
    PubMed        
    
    

    
    Pediatrics

38. WOODGATE T, Patel J, Day T, Knight B, et al
    Pulmonary Hypertension Associated With Vitamin C Deficiency Is Rapidly Reversible.
    Pediatrics. 2026 Mar 17:e2025073645. doi: 10.1542/peds.2025-073645.
    PubMed         Abstract available
    
    

    
    Ren Fail

39. KOOWATTANATIANCHAI S, Kochaiyapatana P, Kanokwatanakul M, Kaladee K, et al
    Pulmonary hypertension in dialysis patients: clinical insights from tricuspid regurgitation velocity (TRV)-based echocardiographic criteria.
    Ren Fail. 2026;48:2639889.
    PubMed         Abstract available
    
    

    
    Respir Med

40. VILLASMIL HERNANDEZ N, Nunez N, Tonelli AR, Heresi GA, et al
    The impact of age on six-minute walk distance, functional class, and right ventricular function in pulmonary arterial hypertension.
    Respir Med. 2026;254:108742.
    PubMed         Abstract available
    
    

    
    Respir Med Res

41. VALENTIN S, Odille F, Fraix A, Pace N, et al
    Cardiac MRI differentiates classical idiopathic pulmonary arterial hypertension from lung phenotype and group 3 pulmonary hypertension.
    Respir Med Res. 2026;89:101256.
    PubMed         Abstract available
    
    

    
    Rheumatology (Oxford)

42. BRAVO-MARQUES R, Rivas-Ruiz F, Tenes A, Becerra-Munoz VM, et al
    New phenotype and outcomes in connective tissue disease-associated pulmonary arterial hypertension: relevance of age-related comorbidities.
    Rheumatology (Oxford). 2026;65:keag105.
    PubMed         Abstract available
    
    

    
    Ter Arkh

43. ERSHOV AV, Mikhailova OO, Elfimova EM, Mershin KV, et al
    [Sleep disorders dynamics in patients with chronic thromboembolic pulmonary hypertension after surgical treatment].
    Ter Arkh. 2026;98:176-182.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Pulmonary Hypertension is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum